Pengo V
Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova School of Medicine, Ex Busonera Hospital, via Gattamelata, 64 I-35128 Padova, Italy.
Compr Ther. 2001 Spring;27(1):7-10. doi: 10.1007/s12019-001-0002-8.
Many factors can influence the final decision to treat nonrheumatic atrial fibrillation in the very elderly patient with anticoagulants. Therefore, a systemic approach in which the thromboembolic and hemorrhagic risk profiles are taken into account is suggested.